Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
Daniele Fanale, Lidia Rita Corsini, R. Scalia, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 170, pp. 103597-103597
Closed Access | Times Cited: 24

Showing 24 citing articles:

Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
Daniele Fanale, Alessandra Dimino, Erika Pedone, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4344-4344
Open Access | Times Cited: 29
Immunotherapy for Ovarian Cancer: Disappointing or Promising?
Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 454-466
Closed Access | Times Cited: 8
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
Yurong Peng, Zhuo Li, Yucheng Fu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Advances in immunotyping of colorectal cancer
Wu Yinhang, Zhuang Jing, Zhanbo Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiology
Ioannis A. Voutsadakis
Cancer Treatment and Research Communications (2023) Vol. 36, pp. 100746-100746
Open Access | Times Cited: 12
Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
Lingling Li, Dongxian Jiang, Hui Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors.
Jian Li, Ye Xu, Aimin Zang, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 257-269
Closed Access | Times Cited: 4
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
Daniele Fanale, Alessia Pivetti, D. Cancelliere, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103626-103626
Closed Access | Times Cited: 14
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
Mihir Bikhchandani, Farin Amersi, Andrew Hendifar, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1054-1054
Open Access | Times Cited: 6
Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC
Jielin Chen, Qijia Yan, Jingyue Sun, et al.
Journal of Cancer (2023) Vol. 14, Iss. 7, pp. 1132-1140
Open Access | Times Cited: 5
Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
Atsushi Tatsuguchi, Takeshi Yamada, Kohji Ueda, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Biomarkers for immunotherapy resistance in non-small cell lung cancer
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
Chang Liu, Zhihua Lü, Jun Yan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 190, pp. 104086-104086
Open Access | Times Cited: 3
A m6A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma
Mengyuan Lei, Chenghan Luo, Jiayang Zhang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 931-949
Closed Access | Times Cited: 5
Case report: Undifferentiated sarcoma with multiple tumors involved in Lynch syndrome: Unexpected favorable outcome to sintilimab combined with chemotherapy
Jiaying Liu, Xiaona Chang, Guixiang Xiao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Histologic and Immunochemical Assessment of Colorectal Cancers
Dale Telgenhoff, Brooke H. Dubansky, Sally Lewis
American Society for Clinical Laboratory Science (2024)
Open Access
A novel immunohistochemical score predicts the postoperative prognosis of gastric cancer patients
Feng Liu, Xiao‐Yang Wu, Weiping Wang, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Endometrial hyperplasia and microsatellite instability: possibilities for predicting tumor transformation of the endometrium
E.L. Kazachkov, E.A. Kazachkova, Е.Е. Воропаева, et al.
CLINICAL AND EXPERIMENTAL MORPHOLOGY (2023) Vol. 12, Iss. 4, pp. 14-22
Open Access | Times Cited: 1
Research Progress in Prognostic Markers of Immunotherapy for Non-Small Cell Lung Cancer
科宇 张
Advances in Clinical Medicine (2023) Vol. 13, Iss. 01, pp. 264-271
Closed Access
Avances y perspectivas de la inmunoterapia perioperatoria en el cáncer de pulmón no-microcítico
Yurong Peng, Zhuo Li, Yucheng Fu, et al.
Kompass Neumología (2023) Vol. 5, Iss. 2, pp. 47-58
Open Access
Precision Oncology: Next Steps
Jesús García‐Foncillas
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 867-868
Open Access
Page 1

Scroll to top